Effect of portal pressure gradient reduction on outcomes after transjugular intrahepatic portosystemic shunt in portal hypertension patients

doi:10.4254/wjh.v17.i3.103261

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (667)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-6) series.

Item

Count

PDF

HTML

378

Figures (1-6)

Tables (1-6)

Sum=566

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=71

Mar 27, 2025 (publication date) through Apr 27, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Hepatol. Mar 27, 2025; 17(3): 103261
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.103261

Table 5 Univariate and multivariate Cox regression analyses for liver failure before and after propensity score matching

Characteristics	Before PSM, univariate analyses (n = 815)			Before PSM, multivariate analyses (n = 815)			After PSM, univariate analyses (n = 662)			After PSM, univariate analyses (n = 662)
Characteristics	HR	95%CI	P	HR	95%CI	P	HR	95%CI	P	HR	95%CI	P
Group B	2.166	1.288-3.643	0.004^b	2.523	1.486-4.283	0.001^b	2.238	1.284-3.901	0.005^b	2.241	1.276-3.937	0.005^b
Creatinine	2.802	1.536-5.110	0.001^b	3.096	1.702-5.630	< 0.001^b	2.529	1.287-4.970	0.007^b	3.12	1.500-6.486	0.002^b
Right hepatic venous wedge pressure	2.614	1.223-5.586	0.013^a	2.643	1.229-5.680	0.013^a	1.941	0.858-4.392	0.112
Alanine aminotransferase	1.45	0.979-2.146	0.064				1.683	1.091-2.598	0.019^a	1.541	1.003-2.366	0.048^a
Cancer antigen 153	0.727	0.484-1.092	0.124				0.814	0.511-1.299	0.389
Platelet count	1.265	0.893-1.794	0.186				1.261	0.855-1.859	0.242
Carcinoembryonic antigen	0.877	0.639-1.202	0.414				0.852	0.597-1.218	0.38
C-Reactive protein							1.166	1.049-1.296	0.004^b	1.138	1.022-1.267	0.019^a
Alkaline phosphatase							1.461	0.909-2.348	0.117
Pre-TIPS right atrial pressure							1.595	0.882-2.884	0.123
International normalized ratio							0.283	0.044-1.845	0.187
Blood ammonia							0.704	0.440-1.129	0.145
Pre-TIPS MELD score							0.6	0.024-14.884	0.755
Activated partial thromboplastin time							2.952	0.880-9.905	0.08
Hemoglobin							2.551	0.903-7.205	0.077

^aP < 0.05.

^bP < 0.01.

HR: hazard ratio; PSM: Propensity score matching; TIPS: Transjugular intrahepatic portosystemic shunt; MELD: Model for end-stage liver disease.

Citation: Wang ZB, Zhu B, Meng MM, Wu YF, Zhang Y, Li DZ, Tian H, Wang FC, Lv YF, Ye QX, Liu FQ. Effect of portal pressure gradient reduction on outcomes after transjugular intrahepatic portosystemic shunt in portal hypertension patients. World J Hepatol 2025; 17(3): 103261
URL: https://www.wjgnet.com/1948-5182/full/v17/i3/103261.htm
DOI: https://dx.doi.org/10.4254/wjh.v17.i3.103261